VOYA Investment Management
PHAT icon

VOYA Investment Management’s Phathom Pharmaceuticals PHAT Stock Holding History

VOYA Investment Management’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,823
Closed -$113K – 2595
2025
Q2 		$113K Buy
11,823
+753
+7% +$4.17K ﹤0.01% 2458
2025
Q1 		$69.4K Sell
11,070
-619
-5% -$3.76K ﹤0.01% 2500
2024
Q4 		$94.9K Buy
11,689
+325
+3% +$4.03K ﹤0.01% 2590
2024
Q3 		$205K Sell
11,364
-327
-3% -$4.57K ﹤0.01% 2466
2024
Q2 		$120K Buy
11,691
+672
+6% +$6.92K ﹤0.01% 2622
2024
Q1 		$117K Sell
11,019
-1,824
-14% -$15.5K ﹤0.01% 2597
2023
Q4 		$117K Hold
12,843
– – ﹤0.01% 2719
2023
Q3 		$133K Buy
12,843
+2,798
+28% +$38.4K ﹤0.01% 2661
2023
Q2 		$144K Buy
+10,045
New +$116K ﹤0.01% 2690
2021
Q4 		– Sell
-7,968
Closed -$256K – 2814
2021
Q3 		$256K Hold
7,968
– – ﹤0.01% 2431
2021
Q2 		$270K Buy
+7,968
New +$285K ﹤0.01% 2425

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

VOYA Investment Management's PHAT Position: Q3 2025 in Review

VOYA Investment Management sold out of Phathom Pharmaceuticals (PHAT) in Q3 2025, closing a stake of 11,823 shares — an estimated $113K sold.

VOYA Investment Management first reported a position in PHAT in Q2 2021 and held it in 11 quarters. The position peaked at $270K in Q2 2021. 133 funds tracked by Wall St. Rank hold PHAT as of Q3 2025.

  • VOYA Investment Management reported no remaining Phathom Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 11,823 Phathom Pharmaceuticals shares in Q3 2025, an estimated $113K.
  • VOYA Investment Management first reported a position in Phathom Pharmaceuticals in Q2 2021 and held it in 11 quarters.
  • VOYA Investment Management's Phathom Pharmaceuticals position peaked at $270K in Q2 2021.
  • 133 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.